Erb News Network

Weight loss drugs like Ozempic and Wegovy linked to sudden blindness – NaturalNews.com

• The EMA confirms that Ozempic and Wegovy double the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare but devastating condition causing permanent vision loss.
• Multiple documented cases reveal patients waking up blind after just one dose, with others experiencing retinal bleeding and irreversible damage—yet Novo Nordisk denies definitive proof while being forced to update warning labels.
• Experts suspect rapid glucose drops from GLP-1 drugs deprive the optic nerve of oxygen, triggering NAION—a risk tripled compared to a decade ago, per Harvard researcher Dr. David Sinclair.
• Despite harrowing reports, the EMA and U.K.’s MHRA delayed warnings, downplaying risks as “extremely small”—another example of regulatory capture favoring Big Pharma profits over public safety.
• Diet, exercise and metabolic therapies can achieve similar benefits without risking blindness, proving yet again that independent research exposes dangers long before captured agencies admit them.

A shocking new warning from European regulators confirms what independent researchers have long suspected: popular weight-loss and diabetes drugs like Ozempic and Wegovy may cause sudden, irreversible blindness. The European Medicines Agency (EMA) has officially linked semaglutide-based medications to non-arteritic anterior ischemic optic neuropathy (NAION), a rare but devastating condition that cuts off blood flow to the optic nerve, leading to permanent vision loss.